While it would be unwise to consider SARS-CoV-2 as evolutionarily exhausted, it is beginning to struggle to find new evolutionary improvements.

If the disease is defeated, immunity is more comprehensive, but less potent. It is therefore recommended that at least one dose of the vaccine be administered to people who have had the disease.

The author reminds us that we are going into a pandemic summer and the situation will remain for a long time. We must be optimist, but remain cautious.

Science has shown us that alcohol use disorder is a chronic and relapsing disease, but talking about it in our culture is still complicated.

Maria Garcés-Sánchez, specialist in paediatrics and researcher in the Vaccines Area at FISABIO, explains why vaccinating children against COVID-19 is not a priority at the moment.

The vaccine protects us against severe forms of COVID-19, but does it prevent us from catching it or infecting others?

The idea of citizen science brings with it tensions about the social nature of scientific truth.

The new coronavirus strain identified in the United Kingdom presents different mutations. Alma Bracho, FISABIO researcher, explains.

We review, through articles published in Mètode, the news during these twelve months of SARS-CoV-2 health crisis.

The author discusses how women have been rendered invisible during the COVID-19 pandemic and how we have experienced a regression in gender biases.

Is it useful to talk about COVID-19 waves, or maybe other metaphorss such as forest fires can be more adequate?

Essentially there is no supplement that can prevent the coronavirus, but many patients who have suffered from the coronavirus have vitamin D deficiency.

The virus has spread again in the different populations because we have lowered our protective measures, when we should have maintained them for a much longer period.

On 9 November, Pfizer announced in a press release that their COVID-19 vaccine candidate shows 90 % efficacy. We analyse the situation with the voice of several experts.

The Nobel Prize for Chemistry has awarded Emmanuelle Charpentier and Jennifer A. Doudna for the development of CRISPR-Cas9 genetic editing tools. Lluís Montoliu analyses the journey to this award.

Vaccine development takes a long time, often more than fifteen years. The SARS-CoV-2 pandemic has accelerated the process in record time. This race has only just begun and there is much to be learned in the near future.

Fernando Ballesteros discusses the discovery of phosphine on Venus and other historical hypotheses regarding signs of life on other planets.

Through several maps, the text shows COVID-19's cartography and analyses the environmental factors that may have contributed to its spread.

Those of us who are dedicated to the creation and dissemination of knowledge must make intelligent use of its contingent and provisional nature, to promote the idea that what may appear to be weaknesses are, in fact, the features that allow scientific knowledge to progress and be disruptive.

The problem with the handling of COVID-19 in the United States has been more political than public health-related. When a country has a president who «didn’t know» and thought that «most people didn’t know» that the flu can kill people, what can be expected in terms of the handling of a pandemic?

Early criticism of COVID-19 rhetoric cautions against the use of war metaphors that can shift us toward authoritarian and nationalistic sentiment, evoking xenophobia and racism.

Most of the fake news that circulated on the web before this pandemic concerned health and became far more widespread than the real news. Unfortunately, this phenomenon has escalated with the global COVID-19 crisis.

In addition to protective isolation, enhanced medical capacity, safer sociality and health oriented economic stimulus, we will need to turn our hearts, hands, and minds to reweaving and strengthening the complex and vital social web.